Among women with an intact uterus, the risks of stroke, invasive breast cancer, colorectal cancer, endometrial cancer and pulmonary embolism/deep vein thrombosis were not significantly different between vaginal estrogen users and nonusers. The risks of coronary heart disease, fracture and premature death were lower in users than non-users. The risks of coronary heart disease, stroke, cancer and pulmonary embolism/deep vein thrombosis for women who had undergone hysterectomies were not significantly different in users of vaginal estrogen compared to nonusers.
‘In women who are experiencing or have experienced menopause, vaginal estrogen is used to treat vaginal dryness, itching, and burning and sudden need to urinate immediately.’
The study, the first to examine potential adverse health effects in users of vaginal estrogen compared with non-users, suggested that vaginal estrogen therapy is a safe treatment for genitourinary symptoms such as burning, discomfort, and pain during intercourse associated with menopause. The study is published in the journal Menopause.
Source: ANI